Rigshospitalet, Denmark: Leukemia trials

The registry lists 11 Leukemia studies with Rigshospitalet, Denmark as lead sponsor. 3 are open to participants now and 1 have results posted.

Phase 2 2Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic LeukemiaRecruitingNCT05639673
• Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML ProfilingRecruitingNCT05431257Phase 2
• Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic LeukemiaRecruitingNCT04209244Not applicable
• NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic LeukemiaCompletedNCT00548431Phase 2Results posted
• Feasiblity and Safety of Home-based Intensive ChemotherapyCompletedNCT04904211Not applicable
• Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During TreatmentCompletedNCT03493906Not applicable
• Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALLCompletedNCT01896752
• The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic LeukemiaCompletedNCT01886651
• Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic LeukemiaCompletedNCT01678508
• ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG AsparaginaseCompletedNCT00819351Phase 3
• ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation TherapyCompletedNCT00816049Phase 3